1. Home
  2. ESPR vs PRCH Comparison

ESPR vs PRCH Comparison

Compare ESPR & PRCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • PRCH
  • Stock Information
  • Founded
  • ESPR 2008
  • PRCH 2012
  • Country
  • ESPR United States
  • PRCH United States
  • Employees
  • ESPR N/A
  • PRCH N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • PRCH Computer Software: Prepackaged Software
  • Sector
  • ESPR Health Care
  • PRCH Technology
  • Exchange
  • ESPR Nasdaq
  • PRCH Nasdaq
  • Market Cap
  • ESPR 202.2M
  • PRCH 656.3M
  • IPO Year
  • ESPR 2013
  • PRCH N/A
  • Fundamental
  • Price
  • ESPR $1.17
  • PRCH $12.11
  • Analyst Decision
  • ESPR Buy
  • PRCH Strong Buy
  • Analyst Count
  • ESPR 6
  • PRCH 8
  • Target Price
  • ESPR $6.50
  • PRCH $10.28
  • AVG Volume (30 Days)
  • ESPR 3.2M
  • PRCH 2.3M
  • Earning Date
  • ESPR 08-11-2025
  • PRCH 08-05-2025
  • Dividend Yield
  • ESPR N/A
  • PRCH N/A
  • EPS Growth
  • ESPR N/A
  • PRCH N/A
  • EPS
  • ESPR N/A
  • PRCH N/A
  • Revenue
  • ESPR $259,574,000.00
  • PRCH $427,150,000.00
  • Revenue This Year
  • ESPR $4.07
  • PRCH $4.28
  • Revenue Next Year
  • ESPR N/A
  • PRCH $12.88
  • P/E Ratio
  • ESPR N/A
  • PRCH N/A
  • Revenue Growth
  • ESPR 12.99
  • PRCH N/A
  • 52 Week Low
  • ESPR $0.69
  • PRCH $1.05
  • 52 Week High
  • ESPR $3.94
  • PRCH $12.83
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 61.04
  • PRCH 65.99
  • Support Level
  • ESPR $0.95
  • PRCH $10.55
  • Resistance Level
  • ESPR $1.06
  • PRCH $12.83
  • Average True Range (ATR)
  • ESPR 0.08
  • PRCH 0.74
  • MACD
  • ESPR -0.00
  • PRCH 0.06
  • Stochastic Oscillator
  • ESPR 81.48
  • PRCH 81.16

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About PRCH Porch Group Inc.

Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions. Majority revenue is from Insurance segment.

Share on Social Networks: